Business Overview: Elite Health Systems Inc. (OTC: EHSI)

Executive Summary: Elite Health Systems Inc. is an early-stage, micro-cap health plan holding company that, through its subsidiary Elite Health Plan, Inc., recently obtained a Knox-Keene license to operate Medicare Advantage plans in the Los Angeles, Riverside, and San Bernardino county markets of California, with enrollment beginning January 2026. The company also owns Physician Support Systems Inc. (PSS), acquired in November 2025, which provides practice-management and employee-leasing services to medical practices. As of fiscal year-end 2025 the company had essentially no Medicare Advantage revenue, a net loss of roughly $7.8 million, and limited cash reserves, making it a pre-commercialization story rather than an established operator.

1. Core Business Model & How They Work

Elite Health Systems is structured as a holding company with two operating pieces. The first, Elite Health Plan, is pursuing the classic Medicare Advantage (Part C) insurer model: it contracts with the Centers for Medicare & Medicaid Services (CMS) to receive a per-member-per-month capitated payment for each Medicare-eligible senior it enrolls, and in exchange assumes the risk (and opportunity) of managing that member's medical costs within a provider network. The second piece, PSS, generates fee and employee-leasing revenue by providing back-office, compliance, and operational support to independent physician practices — a business that is cash-generative today and is intended to help fund and cross-sell into the health plan buildout.

 Medicare-eligible      Enrolls in Elite        CMS pays monthly       Elite manages
 senior in LA/          Health Plan (Knox-  -->  capitated premium --> network costs,
 Riverside/San           Keene licensed          per member             pockets margin
 Bernardino counties     Medicare Advantage                              (or loss)
        |                      plan
        |
        v
 Physician practices  -->  PSS provides staffing/     -->  PSS earns management
 (independent of           practice-mgmt/compliance        & leasing fees
 Elite's own plan)         services

2. Business Segments

The 10-K does not yet present multiple mature reporting segments with meaningful revenue history; operations are effectively organized around two subsidiaries:

• Elite Health Plan, Inc. — Medicare Advantage health plan operations (Knox-Keene licensed in California; plans launched January 2026; Chronic Condition Special Needs Plans (C-SNPs) targeted for 2027). Generated essentially $0 of revenue through fiscal 2025 since enrollment had not yet begun.
• Physician Support Systems Inc. (PSS) — Healthcare management/employee-leasing services to medical practices, acquired November 2025. Contributed the company's entire reported FY2025 revenue (approximately $1.0 million), covering only the roughly two months since acquisition.

3. Product Portfolio

• Medicare Advantage (Part C) health plans for seniors and special-needs populations in targeted Southern California counties
• Planned Chronic Condition Special Needs Plans (C-SNPs), targeted for 2027
• Physician practice-management and administrative/compliance consulting (via PSS)
• Employee leasing services to medical practices (via PSS)

4. Competitive Landscape

Elite Health Systems competes in a Medicare Advantage market that is heavily dominated by a small number of national giants. The 10-K itself acknowledges that UnitedHealth Group and Humana together account for nearly half of all Medicare Advantage enrollees nationwide, and the company will also face regional and national managed-care plans, provider-sponsored plans, and other California Knox-Keene licensees in its initial Los Angeles/Riverside/San Bernardino service area. As a new, unscaled entrant with a single-digit-million-dollar balance sheet, Elite Health has essentially no negotiating leverage with providers or payers relative to incumbents, and its near-term competitive position rests on being a small, localized alternative rather than a share-taker from larger plans.

5. Strategic Strengths & Risks

Strengths

• Newly granted Knox-Keene license provides a hard-to-obtain regulatory gateway into the California Medicare Advantage market
• Acquisition of PSS gives the company an existing, revenue-generating healthcare services business and physician relationships that could become a referral/enrollment pipeline for the health plan
• Exposure to a large, structurally growing end market (Medicare Advantage enrollment growth as the U.S. population ages)

Risks

• Essentially pre-revenue in its core health-plan business, with a FY2025 net loss of approximately $7.8 million against total revenue of only about $1.0 million
• Direct competition with vastly larger, better-capitalized national players (UnitedHealth, Humana) that can out-market and out-negotiate a startup plan
• Execution risk in building provider networks, actuarial pricing, and CMS compliance from a standing start, with limited cash on hand (~$3.8 million at year-end 2025) to absorb losses during ramp-up
• Regulatory and licensing risk inherent to a newly licensed, single-state Medicare Advantage operator
• Integration risk from the recent PSS acquisition and reliance on that single ancillary business for current revenue

6. Financial Overview

For fiscal year 2025, Elite Health Systems reported total revenue of approximately $1,024,000, derived entirely from PSS employee-leasing activity following its November 2025 acquisition, and a net loss of approximately $(7,804,000). The company ended the year with cash of approximately $3,758,000. These figures reflect a company that was effectively pre-revenue in its primary intended business (Medicare Advantage) for the full fiscal year, with losses driven by start-up, licensing, and acquisition-related costs rather than by an established, scaled insurance operation.

7. Summary Conclusion

Elite Health Systems is best characterized today as a speculative, early-stage health plan start-up layered on top of a small physician-services business, rather than a proven operator. The Knox-Keene license and PSS acquisition give it a real foothold and a modest revenue base, but the company has yet to demonstrate it can enroll members, manage medical cost ratios, and compete profitably against entrenched national Medicare Advantage incumbents. Investors should view EHSI as a high-risk, pre-commercialization name whose investment case depends almost entirely on successful 2026 plan launch execution.